The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Therapeutic potential of neuropeptide Y (NPY) receptor ligands
Open accessAbstract
Neuropeptide Y (NPY) is widely distributed in the human body and contributes to a vast number of physiological processes. Since its discovery, NPY has been implicated in metabolic regulation and, although interest in its role in central mechanisms related to food intake and obesity has somewhat diminished, the topic remains a strong focus of research concerning NPY signalling. In addition, a number of other uses for modulators of NPY receptors have been implied in a range of diseases, although the development of NPY receptor ligands has been slow, with no clinically approved receptor therapeutics currently available. Nevertheless, several interesting small molecule compounds, notably Y2 receptor antagonists, have been published recently, fueling optimism in the field. Herein we review the role of NPY in the pathophysiology of a number of diseases and highlight instances where NPY receptor signalling systems are attractive therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut hormone PYY3-36 physiologically inhibits food intake
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature · doi:10.1038/nature00887 · Cited by 2,351
Tatemoto, K., Carlquist, M., & Mutt, V. (1982) · Nature · doi:10.1038/296659a0 · Cited by 2,269
Leptin Inhibits Bone Formation through a Hypothalamic Relay
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M., & Karsenty, G. (2000) · Cell · doi:10.1016/s0092-8674(00)81558-5 · Cited by 2,077
The role of neuropeptide Y in the antiobesity action of the obese gene product
Stephens, T. W., Basinski, M., Bristow, P. K., Bue-Valleskey, J. M., Burgett, S. G., Craft, L., Hale, J., Hoffmann, J., Hsiung, H. M., Kriauciunas, A., et al. (1995) · Nature · doi:10.1038/377530a0 · Cited by 1,498
OBESE, A NEW MUTATION IN THE HOUSE MOUSE*
INGALLS, A. M., DICKIE, M. M., & SNELL, G. D. (1950) · Journal of Heredity · doi:10.1093/oxfordjournals.jhered.a106073 · Cited by 1,090
Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y
Erickson, J. C., Clegg, K. E., & Palmiter, R. D. (1996) · Nature · doi:10.1038/381415a0 · Cited by 1,008
A receptor subtype involved in neuropeptide-Y-induced food intake
Gerald, C., Walker, M. W., Criscione, L., Gustafson, E. L., Batzl-Hartmann, C., Smith, K. E., Vaysse, P., Durkin, M. M., Laz, T. M., Linemeyer, D. L., et al. (1996) · Nature · doi:10.1038/382168a0 · Cited by 891
H1-Receptor Antagonists: Comparative Tolerability and Safety
Estelle, F., & Simons, R. (1994) · Drug Safety · doi:10.2165/00002018-199410050-00002 · Cited by 751
Tatemoto, K., & Mutt, V. (1980) · Nature · doi:10.1038/285417a0 · Cited by 659
Kuo, L. E., Kitlinska, J. B., Tilan, J. U., Li, L., Baker, S. B., Johnson, M. D., Lee, E. W., Burnett, M. S., Fricke, S. T., Kvetnansky, R., et al. (2007) · Nature Medicine · doi:10.1038/nm1611 · Cited by 656
Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides
Wahlestedt, C., Yanaihara, N., & Håkanson, R. (1986) · Regulatory Peptides · doi:10.1016/0167-0115(86)90048-0 · Cited by 631
Self-citationThe NPY system in stress, anxiety and depression
Heilig, M. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.05.002 · Cited by 614
Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense Oligodeoxynucleotides
Wahlestedt, C., Pich, E. M., Koob, G. F., Yee, F., & Heilig, M. (1993) · Science · doi:10.1126/science.8380941 · Cited by 527
Self-citationIsolation and characterization of a new pancreatic polypeptide hormone.
Kimmel, Jr., Hayden, L., & Pollock, H. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40653-4 · Cited by 449
Cloned human neuropeptide Y receptor couples to two different second messenger systems.
Herzog, H., Hort, Y. J., Ball, H. J., Hayes, G., Shine, J., & Selbie, L. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.5794 · Cited by 434
Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type.
Larhammar, D., Blomqvist, A. G., Yee, F., Jazin, E., Yoo, H., & Wahlested, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49854-2 · Cited by 422
Role of the Y5 neuropeptide Y receptor in feeding and obesity
Marsh, D. J., Hollopeter, G., Kafer, K. E., & Palmiter, R. D. (1998) · Nature Medicine · doi:10.1038/nm0698-718 · Cited by 416
Neuropeptide Y: A Novel Angiogenic Factor From the Sympathetic Nerves and Endothelium
Zukowska-Grojec, Z., Karwatowska-Prokopczuk, E., Rose, W., Rone, J., Movafagh, S., Ji, H., Yeh, Y., Chen, W.-T., Kleinman, H. K., Grouzmann, E., et al. (1998) · Circulation Research · doi:10.1161/01.res.83.2.187 · Cited by 378
Bard, J. A., Walker, M. W., Branchek, T. A., & Weinshank, R. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26762 · Cited by 376
Neuropeptide Y functions as a neuroproliferative factor
Hansel, D. E., Eipper, B. A., & Ronnett, G. V. (2001) · Nature · doi:10.1038/35073601 · Cited by 349
Hypothalamic Y2 receptors regulate bone formation
Baldock, P. A., Sainsbury, A., Couzens, M., Enriquez, R. F., Thomas, G. P., Gardiner, E. M., & Herzog, H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214588 · Cited by 349
Patterns of gene expression are altered in the frontal and motor cortices of human alcoholics
Mayfield, R. D., Lewohl, J. M., Dodd, P. R., Herlihy, A., Liu, J., & Harris, R. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00860.x · Cited by 315
Neurobiology of substance P and the NK1 receptor.
Mantyh, P. W. (2002) · PubMed · Cited by 284
Cloning and Expression of a Novel Neuropeptide Y Receptor
Weinberg, D. H., Sirinathsinghji, D. J. S., Tan, C. P., Shiao, L.-L., Morin, N., Rigby, M. R., Heavens, R. H., Rapoport, D. R., Bayne, M. L., Cascieri, M. A., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16435 · Cited by 275
Gerald, C., Walker, M. W., Vaysse, P. J.-J., He, C., Branchek, T. A., & Weinshank, R. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26758 · Cited by 272
Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor
Naveilhan, P., Hassani, H., Canals, J. M., Ekstrand, A. J., Larefalk, Å., Chhajlani, V., Arenas, E., Gedda, K., Svensson, L., Thoren, P., et al. (1999) · Nature Medicine · doi:10.1038/13514 · Cited by 270
Cloning and Functional Expression of a cDNA Encoding a Human Type 2 Neuropeptide Y Receptor
Rose, P. M., Fernandes, P., Lynch, J. S., Frazier, S. T., Fisher, S. M., Kodukula, K., Kienzle, B., & Seethala, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.22661 · Cited by 265
Hippocampal neurogenesis as a target for the treatment of mental illness: A critical evaluation
DeCarolis, N. A., & Eisch, A. J. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.013 · Cited by 252
Chemically Mediated Cross-Excitation in Rat Dorsal Root Ganglia
Amir, R., & Devor, M. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-15-04733.1996 · Cited by 230
Neuropeptide Y Receptor Subtypes, Y1 and Y2
WAHLESTEDT, C., GRUNDEMAR, L., HÅKANSON, R., HEILIG, M., SHEN, G. H., ZUKOWSKA‐GROJEC, Z., & REIS, D. J. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb48918.x · Cited by 224
Self-citationObesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice
Kushi, A., Sasai, H., Koizumi, H., Takeda, N., Yokoyama, M., & Nakamura, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15659 · Cited by 219
Novel Role of Y1 Receptors in the Coordinated Regulation of Bone and Energy Homeostasis
Baldock, P. A., Allison, S. J., Lundberg, P., Lee, N. J., Slack, K., Lin, E.-J. D., Enriquez, R. F., McDonald, M. M., Zhang, L., During, M. J., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700644200 · Cited by 202
Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor
Naveilhan, P., Hassani, H., Lucas, G., Blakeman, K. H., Hao, J.-X., Xu, X.-J., Wiesenfeld-Hallin, Z., Thorén, P., & Ernfors, P. (2001) · Nature · doi:10.1038/35054063 · Cited by 194
OBESE, A NEW MUTATION IN THE HOUSE MOUSE*
Ingalls, A. M., Dickie, M. M., & Snell, G. D. (1996) · Obesity Research · doi:10.1002/j.1550-8528.1996.tb00519.x · Cited by 191
BIIE0246: A selective and high affinity neuropeptide Y Y2 receptor antagonist
Doods, H., Gaida, W., Wieland, H. A., Dollinger, H., Schnorrenberg, G., Esser, F., Engel, W., Eberlein, W., & Rudolf, K. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00650-0 · Cited by 189
Ekstrand, A. J., Cao, R., Björndahl, M., Nyström, S., Jönsson-Rylander, A.-C., Hassani, H., Hallberg, B., Nordlander, M., & Cao, Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1135965100 · Cited by 188
Erondu, N., Gantz, I., Musser, B., Suryawanshi, S., Mallick, M., Addy, C., Cote, J., Bray, G., Fujioka, K., Bays, H., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.08.002 · Cited by 183
Wahlestedt, C., Regunathan, S., & Reis, D. J. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90342-m · Cited by 179
Self-citationPeptide YY abnormalities in gastrointestinal diseases
Adrian, T. E., Savage, A. P., Bacarese-Hamilton, A. J., Wolfe, K., Besterman, H. S., & Bloom, S. R. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90936-4 · Cited by 176
Lappalainen, J., Kranzler, H. R., Malison, R., Price, L. H., Van Dyck, C., Rosenheck, R. A., Cramer, J., Southwick, S., Charney, D., Krystal, J., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.9.825 · Cited by 176
Y4 receptor knockout rescues fertility in ob/ob mice
Sainsbury, A., Schwarzer, C., Couzens, M., Jenkins, A., Oakes, S. R., Ormandy, C. J., & Herzog, H. (2002) · Genes & Development · doi:10.1101/gad.979102 · Cited by 170
Gregor, P., Feng, Y., DeCarr, L. B., Cornfield, L. J., & McCaleb, M. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27776 · Cited by 168
Kuo, L. E., Czarnecka, M., Kitlinska, J. B., Tilan, J. U., Kvetňanský, R., & Zukowska, Z. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1410.035 · Cited by 167
Reduced Neuropeptide Y Concentrations in Suicide Brain
Widdowson, P. S., Ordway, G. A., & Halaris, A. E. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08877.x · Cited by 159
Movafagh, S., Hobson, J. P., Spiegel, S., Kleinman, H. K., & Żukowska, Z. (2006) · The FASEB Journal · doi:10.1096/fj.05-4770fje · Cited by 155
Relevance of Neuropeptide Y (NPY) in Psychiatry
Eaton, K., Sallee, F. R., & Sah, R. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607782341037 · Cited by 149
NEUROPEPTIDE Y IN PHAEOCHROMOCYTOMAS AND GANGLIONEUROBLASTOMAS
Adrian, T. E., Terenghi, G., Brown, M. J., Allen, J. M., Bacarese-Hamilton, A. J., Polak, J. M., & Bloom, S. R. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90570-6 · Cited by 146
Inactivation of a Novel Neuropeptide Y/Peptide YY Receptor Gene in Primate Species
Matsumoto, M., Nomura, T., Momose, K., Ikeda, Y., Kondou, Y., Akiho, H., Togami, J., Kimura, Y., Okada, M., & Yamaguchi, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27217 · Cited by 146
Fat-induced ileal brake in the dog depends on peptide YY
Lin, H., Zhao, X., Wang, L., & Wong, H. C. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613054 · Cited by 146
Lundberg, P., Allison, S. J., Lee, N. J., Baldock, P. A. J., Brouard, N., Rost, S., Enriquez, R. F., Sainsbury, A., Lamghari, M., Simmons, P. J., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609629200 · Cited by 145
Kitlinska, J. B., Abe, K., Kuo, L. E., Pons, J., Yu, M., Li, L., Tilan, J. U., Everhart, L. M., Lee, E. W., Żukowska, Z., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2192 · Cited by 143
Redrobe, J. P., Dumont, Y., Herzog, H., & Quirion, R. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00374-1 · Cited by 131
Acuna, C., Tamamaki, N., Yanagawa, Y., Obata, K., & van den Pol, A. N. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1008-05.2005 · Cited by 130
Neuropeptide Y in the dentate gyrus
Sperk, G., Hamilton, T. J., & Colmers, W. F. (2007) · Progress in brain research · doi:10.1016/s0079-6123(07)63017-9 · Cited by 129
Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men
Antonijevic, I. A., Murck, H., Bohlhalter, S., Frieboes, R.-M., Holsboer, F., & Steiger, A. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00057-5 · Cited by 128
Neuropeptide tyrosine and pain
Brumovsky, P. R., Shi, T.-J. S., Landry, M., Villar, M. J., & Hökfelt, T. G. M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.12.003 · Cited by 121
Thorsell, A., Slawecki, C. J., Khoury, A. E., Mathé, A. A., & Ehlers, C. L. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.12.005 · Cited by 121
Neuropeptide Y receptors; antisecretory control of intestinal epithelial function
Cox, H. M. (2006) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.10.005 · Cited by 121
Hypothalamic Regulation of Cortical Bone Mass: Opposing Activity of Y2 Receptor and Leptin Pathways
Baldock, P. A. J., Allison, S. J., McDonald, M. M., Sainsbury, A., Enriquez, R. F., Little, D. G., Eisman, J. A., Gardiner, E. M., & Herzog, H. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060705 · Cited by 120
PYY3‐36 as an anti‐obesity drug target
Boggiano, M. M., Chandler-Laney, P. C., Oswald, K. D., Rodgers, R. J., Blundell, J. E., Ishii, Y., Beattie, A. H., Holch, P., Allison, D. B., Schindler, M., et al. (2005) · Obesity Reviews · doi:10.1111/j.1467-789x.2005.00218.x · Cited by 118
Erlinge, D., Brunkwall, J. S., & Edvinsson, L. I. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90006-x · Cited by 110
Martins, P. J. F., Marques, M. S., Tufik, S., & D’Almeida, V. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00660.2009 · Cited by 103
Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis
Decressac, M., Wright, B. L. C., Belin, D., Tyers, P., Jaber, M., Barker, R. A., & Gaillard, A. (2010) · Hippocampus · doi:10.1002/hipo.20765 · Cited by 102
Hulting, J., Sollevi, A., Ullman, B., Franco‐Cereceda, A., & Lundberg, J. M. (1990) · Cardiovascular Research · doi:10.1093/cvr/24.2.102 · Cited by 102
Neuropeptide Y Gene Polymorphisms Confer Risk of Early-Onset Atherosclerosis
Shah, S. H., Freedman, N. J., Zhang, L., Crosslin, D. R., Stone, D. H., Haynes, C. S., Johnson, J., Nelson, S. C., Wang, L., Connelly, J. J., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000318 · Cited by 101
King, P., Widdowson, P. S., Doods, H. N., & Williams, G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730641.x · Cited by 98
Pellieux, C., Sauthier, T., Domenighetti, A. A., Marsh, D. J., Palmiter, R. D., Brunner, H. R., & Pedrazzini, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030533197 · Cited by 92
Wahlestedt, C., Ekman, R., & Widerlöv, E. (1989) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(89)90003-1 · Cited by 90
Self-citationBlockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats
Thorsell, A., Rimondini, R., & Heilig, M. A. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00904-7 · Cited by 89
Rimondini, R., Thorsell, A., & Heilig, M. A. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.084 · Cited by 87
Neuropeptide Y and Drug Development
(1997) · Elsevier eBooks · doi:10.1016/b978-0-12-304990-2.x5000-8 · Cited by 86
NPY regulation of bone remodelling
Lee, N. J., & Herzog, H. (2009) · Neuropeptides · doi:10.1016/j.npep.2009.08.006 · Cited by 86
Wetherill, L., Schuckit, M. A., Hesselbrock, V., Xuei, X., Liang, T., Dick, D. M., Kramer, J., Nurnberger Jr., J. I., Tischfield, J. A., Porjesz, B., et al. (2008) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00790.x · Cited by 83
Caberlotto, L., Thorsell, A., Rimondini, R., Sommer, W. H., Hyytiä, P., & Heilig, M. A. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02162.x · Cited by 82
The neuropeptides CCK and NPY and the changing view of cell-to-cell communication in the taste bud
Herness, S., & Zhao, F. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.02.043 · Cited by 82
Calcitonin Gene-Related Peptide Regulates Expression of Neurokinin1Receptors by Rat Spinal Neurons
Seybold, V. S., McCarson, K. E., Mermelstein, P. G., Groth, R. D., & Abrahams, L. G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01816.2003 · Cited by 78
Brumovsky, P. R., Stanić, D., Shuster, S. J., Herzog, H., Villar, M. J., & Hökfelt, T. G. M. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20639 · Cited by 78
Peripheral hyperalgesia in experimental neuropathy: exacerbation by neuropeptide Y
Tracey, D. J., Romm, M. A., & Yao, N. N. L. (1995) · Brain Research · doi:10.1016/0006-8993(94)01265-j · Cited by 75
Brothers, S. P., Saldanha, S. A., Spicer, T., Cameron, M. D., Mercer, B. A., Chase, P. S., McDonald, P. H., Wahlestedt, C., & Hodder, P. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058677 · Cited by 74
Self-citationNoè, F. M., Vaghi, V., Balducci, C., Fitzsimons, H. L., Bland, R. J., Zardoni, D., Sperk, G., Carli, M., During, M. J., & Vezzani, A. (2010) · Gene Therapy · doi:10.1038/gt.2010.23 · Cited by 70
Dumont, Y., Cadieux, A., Doods, H. N., et al. (2000) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y99-119 · Cited by 68
Schober, D. A., van Abbema, A. M., Smiley, D. L., Bruns, R. F., & Gehlert, D. R. (1998) · Peptides · doi:10.1016/s0196-9781(97)00455-5 · Cited by 68
Parker, E. M. (2004) · Elsevier eBooks · doi:10.1016/b0-12-443710-9/00422-1 · Cited by 68
Cox, H. M., & Tough, I. R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704604 · Cited by 66
Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling
Hassani, H., Lucas, G., Rozell, B., & Ernfors, P. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00182.2004 · Cited by 65
Role of neuropeptide Y Y2 receptors in modulation of cardiac parasympathetic neurotransmission
Smith-White, M. A., Herzog, H., & Potter, E. K. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(01)00368-8 · Cited by 64
Edelsbrunner, M., Painsipp, E., Herzog, H., & Holzer, P. D. (2009) · Neuropeptides · doi:10.1016/j.npep.2009.08.007 · Cited by 62
Correlation of Gut Hormones with Irritable Bowel Syndrome
Zhang, H., Yan, Y., Shi, R., Lin, Z., Wang, M., & Lin, L. (2008) · Digestion · doi:10.1159/000165352 · Cited by 61
Shoblock, J. R., Welty, N., Nepomuceno, D. H., Lord, B., Aluisio, L. E., Fraser, I. C., Motley, S. T., Sutton, S. W., Morton, K. L., Galici, R., et al. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1726-x · Cited by 61
Moran, T. D., Colmers, W. F., & Smith, P. A. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00096.2004 · Cited by 61
Modulation of neuropeptide Y receptors for the treatment of obesity
Sato, N., Ogino, Y., Mashiko, S., & Ando, M. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770903251722 · Cited by 60
Glass, J. D., Guinn, J., Kaur, G., & Francl, J. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07139.x · Cited by 60
Agonist and antagonist activities on human NPFF2 receptors of the NPY ligands GR231118 and BIBP3226
Mollereau, C., Gouardères, C., Dumont, Y., et al. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704049 · Cited by 59
Common neuropeptide Y2 receptor gene variant is protective against obesity among Swedish men
Lavebratt, C., Alpman, A., Persson, B., Arner, P., & Hoffstedt, J. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803188 · Cited by 55
Intracerebroventricular neuropeptide Y protects against stress-induced gastric erosion in the rat
Heilig, M. A., & Murison, R. C. C. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90191-9 · Cited by 55
Gut Hormones: A Weight Off Your Mind
Gardiner, J., Jayasena, C. N., & Bloom, S. R. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01729.x · Cited by 55
Brumovsky, P. R., Hofstetter, C. P., Olson, L., Ohning, G., Villar, M. J., & Hökfelt, T. G. M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.11.069 · Cited by 51
Distribution of neuropeptide Y Y1 receptors in rodent peripheral tissues
Matsuda, H., Brumovsky, P. R., Kopp, J., Pedrazzini, T., & Hökfelt, T. G. M. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10303 · Cited by 51
Assessment of ethanol consumption and water drinking by NPY Y2 receptor knockout mice
Thiele, T. E., Naveilhan, P., & Ernfors, P. (2004) · Peptides · doi:10.1016/j.peptides.2004.03.009 · Cited by 50
Relevance of the Neuropeptide Y System in the Biology of Cancer Progression
Ruscica, M., Dozio, E., Motta, M., et al. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607782341019 · Cited by 49
Neuropeptide Y and sex hormone interactions in humoral and neuronal regulation of bone and fat
Zengin, A., Zhang, L., Herzog, H., Baldock, P. A. J., & Sainsbury, A. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.02.004 · Cited by 48
First selective agonist of the neuropeptide Y1‐receptor with reduced size
Zwanziger, D., Böhme, I., Lindner, D., & Beck‐Sickinger, A. G. (2009) · Journal of Peptide Science · doi:10.1002/psc.1188 · Cited by 45
Multiple receptors and multiple actions
Grundemar, L. (1997) · Elsevier eBooks · doi:10.1016/b978-012304990-2/50002-0 · Cited by 41
McDermott, B. J., Millar, B. C., Dolan, F., et al. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01258-2 · Cited by 31
The therapeutic potential of gut hormone peptide YY3-36 in the treatment of obesity
Small, C. J., & Bloom, S. R. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.5.647 · Cited by 31
Neuropeptide chronomics in clinically healthy young adults: circaoctohoran and circadian patterns
Löckinger, A., Köberle, D., König, P., Saria, A., Herold, M., Cornélissen, G., & Franz Halberg, A. (2004) · Peptides · doi:10.1016/j.peptides.2004.02.008 · Cited by 26
Penner, S. B., Smyth, D. D., & Glavin, G. B. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38298-4 · Cited by 24
Neuropeptide Y2 receptors as drug targets for the central regulation of body weight.
Félétou, M., & Levens, N. R. (2005) · PubMed · Cited by 16
Lunniss, G. E., Barnes, A. A., Barton, N., Biagetti, M., Bianchi, F., Blowers, S. M., Caberlotto, L., Emmons, A., Holmes, I. P., Montanari, D., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.06.035 · Cited by 15
Modulation of Neuropathic Pain by Galanin and Neuropeptide Y at the Level of the Medulla in Rats
Jung, S. J., Chang, J. W., Won, R., et al. (2009) · International Journal of Neuroscience · doi:10.1080/00207450903263661 · Cited by 10
Xs, F., & Jy, Z. (1993) · PubMed · Cited by 9
Cited by
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Integration of optogenetics with complementary methodologies in systems neuroscience
Kim, C. K., Adhikari, A., & Deisseroth, K. (2017) · Nature reviews. Neuroscience · doi:10.1038/nrn.2017.15 · Cited by 690
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
Mulvihill, E. E., & Drucker, D. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1035 · Cited by 609
50 years of hurdles and hope in anxiolytic drug discovery
Griebel, G., & Holmes, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4075 · Cited by 414
Appetite-Controlling Endocrine Systems in Teleosts
Rønnestad, I., Gomes, A. S., Murashita, K., Angotzi, R., Jönsson, E., & Volkoff, H. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00073 · Cited by 265
Metadata
- Authors
- Brothers, S. P., & Wahlestedt, C.
- Venue
- EMBO Molecular Medicine
- Published
- 2010-10-22
- Volume
- 2
- Issue
- 11
- Pages
- 429-439
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2170007502
- Cited by
- 267
- References
- 111
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.